Category: Drug Discovery
Global Drug Discovery
-
Psoriasis Global Market Report 2022
... it emerges from the Covid 19 shut down. Reasons to Purchase Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies. Understand how the market is being affected ... Read More
-
2022 Global Forecast for Osteoarthritis Therapeutics (2023-2028 Outlook)-High Tech & Emerging Markets Report
... global market is expected to increase from USD xx billion in 2022 to USD xx billion by 2028, at a CAGR of xx% from 2023 to 2028. Estimates on equipment or material sales (product shipments ... Read More
-
Dermatology Drugs Market Covering Acne; Dermatitis; Psoriasis; Other Drugs for Dermatology Diseases; Global Summary 2021: Covid 19 Impact and Recovery
... 2020 at a CAGR of 7.33%. The global dermatology drugs market is expected to grow from $37.57 billion in 2020 to $62.82 billion in 2025 at a CAGR of 10.82%. Dermatology Drugs Market Covering Acne; ... Read More
-
Metabolomics Market by Product and Service (Metabolomics Instruments and Metabolomics Bioinformatics Tools & Service), Application (Biomarker Discovery, Drug Discovery, Toxicology Testing, Nutrigenomics, Functional Genomics, Personalized Medicine, and Others), and Indication (Cancer, Cardiovascular Disorders, Neurological Disorders, Inborn Errors of Metabolism, and Others): Global Opportunity Analysis and Industry Forecast, 2021––2030
... Inborn Errors of Metabolism, and Others): Global Opportunity Analysis and Industry Forecast, 2021––2030 Metabolomics is study and analysis of biochemical processes involving intermediates and products of metabolic activity. The products are called as metabolomes that ... Read More
-
Healthcare Artificial Intelligence (AI) Market Forecasts to 2028 – Global Analysis By Technology (Deep Learning, Machine), Application (Drug Discovery, Fraud Detection), End User (Research Laboratories, Hospital) and By Geography
... Healthcare Artificial Intelligence (AI) Market is accounted for $6.66 billion in 2021 and is expected to reach $86.37 billion by 2028 growing at a CAGR of 44.2% during the forecast period. Artificial intelligence was initiated ... Read More
-
Gastrointestinal Drugs Global Market Report 2022
... and senior management with the critical information they need to assess the increasing demand for gastrointestinal drugs. Vitamins and Minerals play a crucial role in the treatment of pateints with Covid 19 as they are ... Read More
-
Global Parkinson’s Disease Treatment Market Size study, By Drug Class (Levodopa/carbidopa, Dopamine Receptor Agonists, MAO-Inhibitors, COMT-inhibitors, Anticholinergics, Other Drugs), By Distribution Channel (Hospital Pharmacies, Retailer Pharmacies, Online Pharmacies), By Patient Care Setting (Hospitals, Clinics), and Regional Forecasts 2022-2028
... Regional Forecasts 2022-2028 Global Parkinson’s Disease Treatment Market is valued approximately USD XX Billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2028. ... Read More
-
Antisense & RNAi Therapeutics Global Market Report 2022
... assess the global antisense & RNAi therapeutics market. This report focuses on antisense & RNAi therapeutics market which is experiencing strong growth. The report gives a guide to the antisense & RNAi therapeutics market which ... Read More
-
HIV Drugs Global Market Report 2022
... and senior management with the critical information they need to assess the increasing demand for HIV Drugs which play a critical role in the treatment of patients with Covid 19. Reasons to Purchase Gain a ... Read More
-
Global Metoprolol Market Size study, by Mode of Administration (Oral and Injectable) by Application (Hypertension, Cardiovascular Diseases, and Others) and Regional Forecasts 2022-2028
... anticipated to grow with a healthy growth rate of more than XX % over the forecast period 2022-2028. Metoprolol is a type of medicine which is a beta-blocker which works affect the response to nerve ... Read More
-
Diabetes Drug Market, Size, Global Forecast 2022-2027, Industry Trends, Share, Growth, Insight, Impact of COVID-19, Company Analysis
... indicated by high blood sugar levels. It is caused by a malfunction in the pancreas, which secretes insulin. Besides, diabetes is also referred to as diabetes mellitus. High blood sugar levels cause thirst, hunger, and ... Read More
-
Global and United States CRM197 Market Report & Forecast 2022-2028
... data of other regions in regional level and county level. Due to the COVID-19 pandemic, the global CRM197 market size is estimated to be worth US$ 177.06 million in 2022 and is forecast to a ... Read More
-
Schizophrenia Drugs Market, Size, Global Forecast 2022-2027, Industry Trends, Share, Growth, Insight, Impact of COVID-19, Company Analysis
... illness that harms a person's lifestyle. Furthermore, schizophrenic patients have a distorted perception of reality. The condition causes a variety of behavioral alterations, such as grouping hallucinations, delusions, and so forth. As a result, medicine ... Read More
-
Down Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Down Syndrome (Genetic Disorders) pipeline landscape. Down syndrome is a genetic disorder that causes lifelong mental retardation, developmental delays and ... Read More
-
Hepatic Encephalopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Hepatic Encephalopathy (Gastrointestinal) pipeline landscape. Hepatic encephalopathy is a worsening of brain function that occurs when the liver is no ... Read More
-
Beta Nerve Growth Factor (Beta NGF or NGF) Drugs In Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
... pipeline Target constitutes close to 14 molecules. Out of which approximately 14 molecules are developed by Companies. The latest report Beta Nerve Growth Factor (Beta NGF or NGF) Drugs In Development by Therapy Areas and ... Read More
-
Global Benign Prostatic Hyperplasia Therapeutics Market Size, Share & Industry Trends Analysis Report By Therapy (Mono Drug Therapy and Combination Drug Therapy), By Therapeutics Class, By Regional Outlook and Forecast, 2021 - 2027
... Benign Prostatic Hyperplasia Therapeutics Market size is expected to reach $7.4 billion by 2027, rising at a market growth of 4.6% CAGR during the forecast period. Benign prostatic hyperplasia (BPH) is a benign swelling of ... Read More
-
Nasopharyngitis (Common Cold) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Nasopharyngitis (Common Cold) (Ear Nose Throat Disorders) pipeline landscape. Nasopharyngitis also known as common cold is an infectious, ... Read More
-
Nocturia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Nocturia (Genito Urinary System And Sex Hormones) pipeline landscape. Nocturia is defined as need to urinate at least twice during the night. ... Read More
-
Transcriptomics Market by Type (Consumables, Instruments, Software, and Services), Technology (Microarrays, Qpcr, and Sequencing Technology), Application (Drug Discovery, Diagnostics & Disease Profiling, and Others): Global Opportunity Analysis and Industry Forecast, 2021–2030
... valued at $5,790.51 million in 2020, and is estimated to reach $11,397.08million by 2030, growing at a CAGR of 7.0% from 2021 to 2030.Transcriptomics is the collection and study of RNA present in different types ... Read More
-
Hematological Malignancies Emerging Therapeutics Market - A Global and Regional Analysis: Focus on Therapeutic Type (Marketed), Potential Pipeline Products, Indication, and Region - Analysis and Forecast, 2021-2031
... Market Segmentation Marketed Drugs - Monoclonal Antibodies and CAR-T Cell Therapy Potential Pipeline Products - Monoclonal Antibodies and CAR-T Cell Therapy Indication - Leukemia, Lymphoma, and Multiple Myeloma Regional Segmentation North America - U.S. and ... Read More
-
Digital Therapeutics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Application [Diabetes, Cardiovascular Diseases, Central Nervous System (CNS) Diseases, Respiratory Diseases, Smoking Cessation, Musculoskeletal Diseases, and Other Applications] and Distribution Channel (Patients, Providers, Payers, and Employers)
... Providers, Payers, and Employers) The global digital therapeutics market is expected to grow from US$ 4,226.94 million in 2021 to US$ 18,061.79 million by 2028; it is estimated to grow at a CAGR of 23.1% ... Read More
-
Global Antisynthetase Syndrome Market Size study, by Symptoms (Muscle Disease, Interstitial Lung Disease, Arthritis) by Gender (Male, Female) by Diagnosis (Clinical Testing, Workup) by Treatment (Medication, Physical Therapy) and Regional Forecasts 2022-2028
... Market is valued approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX % over the forecast period 2022-2028. Antisynthetase Syndrome is a type of ... Read More
-
Indian Clinical Trials Market Size, Share & Trends Analysis Report By Phase (Phase I, Phase II, Phase III, Phase IV), By Study Design (Interventional Trials, Observational Trials, Expanded Access Trials), By Indication, And Segment Forecasts, 2022 - 2030
... to expand at a CAGR of 8.2% from 2022 to 2030. The globalization of clinical trials, growing disease variation and prevalence in the country, adoption of new technology in clinical research, and increasing R&D promoting ... Read More
-
Orphan Drugs Market by Disease Type (Oncological Diseases, Metabolic Diseases, Hematologic & Immunologic Diseases, Infectious Diseases, Neurologic Diseases, and Other Rare Diseases): Global Opportunity Analysis and Industry Forecast, 2021–2030
... valued at $1,40,000.0 million in 2020 and is projected to reach $4,35,686.3 million by 2030 registering a CAGR of 11.8% from 2021 to 2030. The pharmaceutical agents administered to treat, diagnose, and prevent life-threatening diseases ... Read More
Research Assistance
